71 related articles for article (PubMed ID: 1385050)
1. Late-effects after treatment for germ-cell cancer with cisplatin, vinblastine, and bleomycin.
Hansen SW
Dan Med Bull; 1992 Oct; 39(5):391-9. PubMed ID: 1385050
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
[TBL] [Abstract][Full Text] [Related]
4. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
5. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
Vriesendorp R; Aalders JG; Sleijfer DT; Willemse PH; Bouma J; Mulder NH
Cancer Treat Rep; 1984 May; 68(5):779-81. PubMed ID: 6202407
[TBL] [Abstract][Full Text] [Related]
6. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
8. Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer.
Glendenning JL; Barbachano Y; Norman AR; Dearnaley DP; Horwich A; Huddart RA
Cancer; 2010 May; 116(10):2322-31. PubMed ID: 20225230
[TBL] [Abstract][Full Text] [Related]
9. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.
Stoter G; Koopman A; Vendrik CP; Struyvenberg A; Sleyfer DT; Willemse PH; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
J Clin Oncol; 1989 Aug; 7(8):1099-104. PubMed ID: 2474060
[TBL] [Abstract][Full Text] [Related]
10. [Clinical results of combination chemotherapy with cisplatin, vinblastine and bleomycin (pvb) for advanced testicular cancer: evaluation of risk criteria].
Mikami K; Nakagawa S; Sugimoto K; Nomoto T; Urano S; Watanabe H; Iwamoto N; Yamazaki S; Hiratake Y; Maegawa M
Hinyokika Kiyo; 1997 Aug; 43(8):561-6. PubMed ID: 9310778
[TBL] [Abstract][Full Text] [Related]
11. Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer.
Hansen SW; Helweg-Larsen S; Trojaborg W
J Clin Oncol; 1989 Oct; 7(10):1457-61. PubMed ID: 2476531
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcome of metastatic testicular cancer at a single institution in Japan, a country with low incidence of germ cell tumor.
Kawai K; Hinotsu S; Oikawa T; Sekido N; Hattori K; Miyanaga N; Hasegawa Y; Kojima H; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Nov; 36(11):723-30. PubMed ID: 17082218
[TBL] [Abstract][Full Text] [Related]
13. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
[TBL] [Abstract][Full Text] [Related]
14. [Advanced germinal tumors of the testicle: clinical experience with cisplatin, bleomycin and vinblastine (PVB) or etoposide (BEP)].
Alonso Curbera G; González-Manzano R; Aramendía Beitia JM; Martínez Monge R; Agüera Fernández L; Rebollo Liceaga J
Rev Med Univ Navarra; 1993; 38(1):13-8. PubMed ID: 8711305
[TBL] [Abstract][Full Text] [Related]
15. History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.
Sweeney C
Semin Urol Oncol; 2001 Aug; 19(3):170-9. PubMed ID: 11561984
[TBL] [Abstract][Full Text] [Related]
16. [PVB therapy for advanced testicular cancer].
Nakao M; Nakagawa S; Toyoda K; Nukui M; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Miyakoda K
Hinyokika Kiyo; 1989 Nov; 35(11):1871-5. PubMed ID: 2482672
[TBL] [Abstract][Full Text] [Related]
17. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
Peckham MJ; Horwich A; Blackmore C; Hendry WF
Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750
[TBL] [Abstract][Full Text] [Related]
18. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Bokemeyer C; Berger CC; Kuczyk MA; Schmoll HJ
J Clin Oncol; 1996 Nov; 14(11):2923-32. PubMed ID: 8918489
[TBL] [Abstract][Full Text] [Related]
20. The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer.
Petersen PM; Hansen SW
Ann Oncol; 1999 Dec; 10(12):1475-83. PubMed ID: 10643539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
